AKBA
Akebia Therapeutics, Inc. · Healthcare
CEO and President John P. Butler sold $74K of Akebia Therapeutics, Inc.
Sold$73,581
$1.58Price
46,570Shares
−2%Stake
What AKBA did after the filing
- The stock from Fri, Mar 1 close, $1.71
- −18.7%
- S&P 500, same days
- −1.3%
Measured over 30 trading days, to the Apr 15 close.
Traded Thu, Feb 29. Filed Fri, Mar 1, 12:47 PM ET, during the session. Returns use the Mar 1 close and the Apr 15 close. Not investment advice.